A Randomized, Double-blinded, Controlled Clinical Trial Comparing Post-injection Site Pain of Technetium-labeled Tilmanocept Versus Technetium-labeled Sulfur Colloid in Patients Undergoing Sentinel Lymph Node Mapping Procedure for Breast Cancer

Trial Profile

A Randomized, Double-blinded, Controlled Clinical Trial Comparing Post-injection Site Pain of Technetium-labeled Tilmanocept Versus Technetium-labeled Sulfur Colloid in Patients Undergoing Sentinel Lymph Node Mapping Procedure for Breast Cancer

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Tc 99m tilmanocept (Primary) ; Tc 99m sulfur colloid
  • Indications Breast cancer
  • Focus Diagnostic use
  • Most Recent Events

    • 20 Aug 2015 Results published in the Annals of surgical Oncology, as per Navidea media release.
    • 20 Aug 2015 Results published in Navidea media release.
    • 08 Jun 2015 Results presented at the 2015 Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference, according to a Navidea Biopharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top